Cargando…

Low‐level gastrokine 2 promoted progress of NSCLC and as a potential biomarker

BACKGROUND: Gastrokine 2 (GKN2) is significantly downregulated in non‐small cell lung cancer (NSCLC) tissues than in normal tissues (NT), as assessed by mRNA microassay; however, the mechanism and clinical value of GKN2 is unknown in NSCLC. METHODS: A total of 60 NSCLC samples and corresponding NT s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xiang, Shi, Wenjing, Zhou, Huixin, Huang, Xiaolou, Hu, Lijuan, Feng, Jiang, Wang, Yumin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841183/ https://www.ncbi.nlm.nih.gov/pubmed/34970791 http://dx.doi.org/10.1002/jcla.24213

Ejemplares similares

Low‐level EFCAB1 promoted progress by upregulated DNMT3B and could be as a potential biomarker in lung adenocarcinoma
por: Yang, Xiang, et al.
Publicado: (2021)

The role and diagnostic potential of gastrokine 1 in gastric cancer
por: Koper-Lenkiewicz, Olga M, et al.
Publicado: (2019)

The Role of Gastrokine 1 in Gastric Cancer
por: Yoon, Jung Hwan, et al.
Publicado: (2014)

Gastrokine 1 mRNA in human sera is not informative biomarker for gastric cancer
por: Villano, Valentina, et al.
Publicado: (2016)

Epigenetic alterations of gastrokine 1 gene expression in gastric cancer
por: Altieri, Filomena, et al.
Publicado: (2017)

Biochemical Properties of Gastrokine-1 Purified from Chicken Gizzard Smooth Muscle
por: Hnia, Karim, et al.
Publicado: (2008)

The diagnostic value of serum gastrokine 1 (GKN1) protein in gastric cancer
por: Yoon, Jung Hwan, et al.
Publicado: (2019)

Effects of gastrokine-2 expression on gastric cancer cell apoptosis by activation of extrinsic apoptotic pathways
por: SHI, LIN-SEN, et al.
Publicado: (2014)

Gastrokine 1 induces senescence and apoptosis through regulating telomere length in gastric cancer
por: Yoon, Jung Hwan, et al.
Publicado: (2014)

De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancer
por: Steiner, Sabrina, et al.
Publicado: (2022)

Gastrokine-1, an anti-amyloidogenic protein secreted by the stomach, regulates diet-induced obesity
por: Overstreet, Anne-Marie C., et al.
Publicado: (2021)

CircRAPGEF5 Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the miR-1236-3p/ZEB1 Axis and Serves as a Potential Biomarker
por: Zhou, Huixin, et al.
Publicado: (2022)

NUF2 Expression Promotes Lung Adenocarcinoma Progression and Is Associated With Poor Prognosis
por: Jiang, Feng, et al.
Publicado: (2022)

EBNA1 binding and epigenetic regulation of gastrokine tumor suppressor genes in gastric carcinoma cells
por: Lu, Fang, et al.
Publicado: (2014)

Gastrokine 1 Expression in the Human Gastric Mucosa Is Closely Associated with the Degree of Gastritis and DNA Methylation
por: Choi, Won Suk, et al.
Publicado: (2013)

Gastrokine 2 Regulates the Antitumor Effect of JAK2/STAT3 Pathway in Gastric Cancer
por: Zhou, Yu, et al.
Publicado: (2021)

Downregulation of gastrokine-1 in gastric cancer tissues and restoration of its expression induced gastric cancer cells to apoptosis
por: Mao, Wei, et al.
Publicado: (2012)

Retracted: Gastrokine 2 Regulates the Antitumor Effect of JAK2/STAT3 Pathway in Gastric Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Super enhancer‐LncRNA SENCR promoted cisplatin resistance and growth of NSCLC through upregulating FLI1
por: Shen, Qiang, et al.
Publicado: (2022)

Construction and analysis of expression profile of exosomal lncRNAs in pleural effusion in lung adenocarcinoma
por: Huang, Xiaolu, et al.
Publicado: (2022)

Prognostic Value of Gastrokine-2 (GKN2) and Its Correlation with Tumor-Infiltrating Immune Cells in Lung Cancer and Gastric Cancers
por: Liu, Fangteng, et al.
Publicado: (2020)

Low expression of PRKCDBP promoted cisplatin resistance in lung adenocarcinoma by DNMT1 and TNF-α
por: Fu, Jiali, et al.
Publicado: (2020)

STAMBPL1 promotes the progression of lung adenocarcinoma by inhibiting DHRS2 expression
por: Yang, Xiang, et al.
Publicado: (2023)

Repression of YAP by NCTD disrupts NSCLC progression
por: Guo, Jiwei, et al.
Publicado: (2016)

PIG3 promotes NSCLC cell mitotic progression and is associated with poor prognosis of NSCLC patients
por: Li, Ming, et al.
Publicado: (2017)

MALDI‐TOF‐MS analysis in low molecular weight serum peptidome biomarkers for NSCLC
por: Song, Yufan, et al.
Publicado: (2022)

PPA1 promotes NSCLC progression via a JNK- and TP53-dependent manner
por: Luo, Dehong, et al.
Publicado: (2019)

LncRNA LINC01512 Promotes the Progression and Enhances Oncogenic Ability of Lung Adenocarcinoma
por: Chen, Jie, et al.
Publicado: (2017)

HOXD-AS1 functions as an oncogenic ceRNA to promote NSCLC cell progression by sequestering miR-147a
por: Wang, Qinghua, et al.
Publicado: (2017)

CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2022)

Clinical value of combined detection of reactive oxygen species modulator 1 and adenosine deaminase in pleural effusion in the identification of NSCLC associated malignant pleural effusion
por: Zhang, Fan, et al.
Publicado: (2019)

Correction: PPA1 promotes NSCLC progression via a JNK- and TP53-dependent manner
por: Luo, Dehong, et al.
Publicado: (2019)

Hsa_circ_0001869 promotes NSCLC progression via sponging miR-638 and enhancing FOSL2 expression
por: Xu, Pei, et al.
Publicado: (2020)

UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT
por: Zhang, Jiguang, et al.
Publicado: (2022)

IDO1 Promotes the Progression of NSCLC by Regulating the Polarization of M2 Macrophages
por: Chen, Xiao, et al.
Publicado: (2023)

The expression landscape of JAK1 and its potential as a biomarker for prognosis and immune infiltrates in NSCLC
por: Shen, Kaikai, et al.
Publicado: (2021)

Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression
por: Guo, Jiwei, et al.
Publicado: (2018)

SNRPB promotes the tumorigenic potential of NSCLC in part by regulating RAB26
por: Liu, Nianli, et al.
Publicado: (2019)

The Significance of the Alter miR let-7a and miR-335 Expression Level Regulating the CCR7/CCL19 Axis as Potential Biomarkers of Tumor Progression in NSCLC
por: Baran, Kamila, et al.
Publicado: (2022)

GEO Data Mining Identifies OLR1 as a Potential Biomarker in NSCLC Immunotherapy
por: Liu, Bin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_62fi48nro8tf3q9eo2v3nf2uhj